Oculis Holding AG (OCS) Current Leases (2021 - 2026)
Quarterly Current Leases rose 57.11% to $531233.9 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $531233.9 through Mar 2026, up 57.11% year-over-year, with the annual reading at $628087.2 for FY2025, 74.67% up from the prior year.
Oculis Holding AG's Current Leases history spans 6 years, with the latest figure at $531233.9 for Q1 2026.
- Current Leases came in at $531233.9 for Q1 2026, down from $628087.2 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $628087.2 in Q4 2025 to a low of $147399.1 in Q4 2022.
- The 5-year median for Current Leases is $359579.4 (2024), against an average of $341289.4.
- Year-over-year, Current Leases fell 29.58% in 2022 and then soared 83.69% in 2024.
- Oculis Holding AG's Current Leases stood at $147399.1 in 2022, then skyrocketed by 33.08% to $196159.7 in 2023, then surged by 83.31% to $359579.4 in 2024, then skyrocketed by 74.67% to $628087.2 in 2025, then dropped by 15.42% to $531233.9 in 2026.
- Per Business Quant, the three most recent readings for OCS's Current Leases are $531233.9 (Q1 2026), $628087.2 (Q4 2025), and $526296.1 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 83,991.00 |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 7.40 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | - |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 720.00 Mn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 45.66 Mn |
| 10 | Oculis Holding AG | 24.51 Bn | 24.21 Bn | - | 531,233.95 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 531,233.95 |
| Dec 31, 2025 | 628,087.24 |
| Sep 30, 2025 | 526,296.11 |
| Jun 30, 2025 | 374,445.97 |
| Mar 31, 2025 | 338,124.16 |
| Dec 31, 2024 | 359,579.38 |
| Sep 30, 2024 | 362,421.07 |
| Jun 30, 2024 | 361,594.47 |
| Mar 31, 2024 | 208,514.18 |
| Dec 31, 2023 | 196,159.68 |
| Sep 30, 2023 | 206,051.77 |
| Jun 30, 2023 | 196,855.07 |
| Dec 31, 2022 | 147,399.11 |
| Dec 31, 2021 | 209,308.90 |